CN113304227A - 一种治疗神经衰弱、失眠的中药组合物 - Google Patents
一种治疗神经衰弱、失眠的中药组合物 Download PDFInfo
- Publication number
- CN113304227A CN113304227A CN202110568034.0A CN202110568034A CN113304227A CN 113304227 A CN113304227 A CN 113304227A CN 202110568034 A CN202110568034 A CN 202110568034A CN 113304227 A CN113304227 A CN 113304227A
- Authority
- CN
- China
- Prior art keywords
- parts
- insomnia
- traditional chinese
- chinese medicine
- neurasthenia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 36
- 208000007443 Neurasthenia Diseases 0.000 title claims abstract description 26
- 206010003549 asthenia Diseases 0.000 title claims abstract description 26
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 title claims abstract description 20
- 206010022437 insomnia Diseases 0.000 title claims abstract description 20
- 239000000203 mixture Substances 0.000 title claims description 9
- 244000025254 Cannabis sativa Species 0.000 claims abstract description 7
- 241000296615 Celastrus strigillosus Species 0.000 claims abstract description 6
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 6
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 6
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 6
- 241001465382 Physalis alkekengi Species 0.000 claims abstract description 6
- 244000269722 Thea sinensis Species 0.000 claims abstract description 6
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 6
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 244000179525 Dracocephalum moldavica Species 0.000 claims abstract description 5
- 241000604017 Lysimachia sikokiana Species 0.000 claims abstract description 5
- 229940079593 drug Drugs 0.000 claims abstract description 5
- 240000001131 Nostoc commune Species 0.000 claims abstract description 3
- 235000013817 Nostoc commune Nutrition 0.000 claims abstract description 3
- 239000007788 liquid Substances 0.000 claims description 5
- 239000003826 tablet Substances 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 3
- 241001558017 Gynura Species 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 15
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 208000024891 symptom Diseases 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 230000003340 mental effect Effects 0.000 description 4
- 206010033557 Palpitations Diseases 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 230000002996 emotional effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 230000002936 tranquilizing effect Effects 0.000 description 3
- 208000000044 Amnesia Diseases 0.000 description 2
- 208000031091 Amnestic disease Diseases 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010061245 Internal injury Diseases 0.000 description 2
- 230000006986 amnesia Effects 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000244186 Ascaris Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 206010049816 Muscle tightness Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000027520 Somatoform disease Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 230000000949 anxiolytic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000004159 blood analysis Methods 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000005978 brain dysfunction Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000000560 effect on dysphoria Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 201000003102 mental depression Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000015238 neurotic disease Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 208000027753 pain disease Diseases 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000007084 physiological dysfunction Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/09—Lichens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Anesthesiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种治疗神经衰弱、失眠的中药,是由下列重量份的原料药组成:莲子心1.5~3重量份;香排草、香青兰3~9重量份;酸浆草、南蛇藤果、太白茶、太子参9~18重量份;舞草、粉条儿菜15~30重量份。本发明具有治疗效果显著、治疗周期短、无毒副作用等特点。
Description
技术领域
本发明属于中药技术领域,尤其是涉及一种治疗神经衰弱、、失眠的中药。
背景技术
神经衰弱是一种以脑和躯体功能衰弱为主的神经症。以易于兴奋又易于疲劳为特征,常伴有紧张、烦恼、易激惹等情绪症状及肌肉紧张性疼痛、睡眠障碍等生理功能紊乱症状。这些症状不是继发于躯体疾病和脑器质性病变,也不是其他任何精神障碍的一部分。但患者病前可存在持久的情绪紧张和精神压力。西医主要使用谷维素片或抗焦虑、抗抑郁药物治疗神经衰弱,可改善患者的焦虑和抑郁,也可使肌肉放松,消除一些躯体不适感。目前,没有治疗神经衰弱、失眠的特效药。
发明内容
本发明的目的在于改进已有技术的不足而提供一种治疗神经衰弱、失眠的中药组合物,可以有效地改善甚至消除患者的临床症状,具有治疗效果显著、治疗周期短、无毒副作用等特点。
神经衰弱属中医的“郁证”、“不寐”、“心悸”等范畴。是由于患者长期处于精神过度紧张、精神负担过重或受到精神创伤,致使大脑功能失调而产生各种临床症状的一种神经功能性疾病。本病其发病原因,多由七情内伤,尤其与长期精神抑郁、思虑过度、精神紧张关系最为密切。由于情志内伤,往往导致脏腑气血阴阳失调,从而出现一系列临床症状。因此,应从整体上来调节人的机体,以达到彻底治愈的目的。
基于上述理论,本发明提供了一种治疗神经衰弱、失眠的中药,由下列重量份的原料药组成:莲子心1.5~3重量份;香排草、香青兰3~9重量份;酸浆草、南蛇藤果、太白茶、太子参9~18重量份;舞草、粉条儿菜15~30重量份。
在一个优选的实施方案中,所述治疗神经衰弱、失眠的中药组合物由下列重量份的原料药组成:莲子心3重量份;香排草、香青兰9重量份;酸浆草、南蛇藤果、太白茶、太子参18重量份;舞草、粉条儿菜30重量份。
其中,莲子心:味苦;寒。归心;肺;肾经。清心火;平肝火,止血;固精。临床发现对肝火扰心、心肾不交之烦燥不眠疗效显著。
太子参:甘、微苦,平。归脾、肺经。益气健脾,生津润肺。临床发现对心脾两虚、气虚型之心悸失眠,神经衰弱,头昏健忘疗效显著。
太白茶:甘;苦;淡;性凉;归肺;胃;心;肝经。清热生津;醒脑安神。临床发现对阴虚火旺之心烦口渴,神经衰弱,失眠疗效显著。
粉条儿菜:味甘,平。润肺止咳,养心安神,消积驱蛔。临床发现对心脾两虚型神经衰弱疗效显著。
香青兰:味辛、苦,凉。清肺解表,凉肝止血。临床发现对痰热内扰型神经衰弱疗效显著。
香排草:味甘,平。祛风,止咳,调经。临床发现对痰热内扰型神经衰弱有很好疗效。
舞草:微涩,平。安神,镇静,祛瘀生新,活血消肿。临床发现对血瘀阻络之神经衰弱疗效显著。
酸浆草:味酸,凉。归大肠;小肠经。清热利湿,解毒消肿。临床发现对神经衰弱疗效显著。
南蛇藤果:甘、苦,平。安神镇静。临床发现对血瘀阻络之神经衰弱,失眠,心悸,健忘疗效显著。注意孕妇忌服。
本发明是由中国传统的中草药制成,根据中医辨证论治及现代医学的若干原则,以某些成分确定、功效明晰的天然提取物的有序配伍,组合成了有效治疗神经衰弱、失眠的中药。
本发明可以贯穿于神经衰弱、失眠治疗的全过程,临床实验结果显示,用本药方施治,每日一剂,水煎100-150ml,分成两份,早晚各一份服用,以一个月为一疗程,一般一个疗程见效,三个疗程可见明显改善,疗效显著,标本兼治,治愈率高,安全可靠,无明显毒副反应,便于患者长期坚持服用,用药多年来,患者无任何不良反应,跟踪血液检查正常。
本发明的中药组合物原料易得,工艺简单,成本低,效率高,有利于制药企业进行药品生产、质量控制;产品价格低,易于被患者接受。
本发明还提供了一种由上述治疗神经衰弱、失眠的中药组合物制成的口服制剂,所述口服制 剂包括口服液、片剂、胶囊剂、丸剂等,优选剂型为片剂和胶囊剂,一日一剂,分早晚两次服用。
本发明的中药组合物可以制备成多种剂型。例如,将煎煮后的药液杀菌消毒后装袋,制成口服液;或者将煎煮后的药液进行浓缩,烘干后,加入医学上可接收的辅料,然后制成片剂、胶囊剂、丸剂等。
所述医学上可接收的辅料包括淀粉、糊精、羧甲基纤维素钠、聚乙二醇、磷酸氢钙、海藻酸钠、山梨酸钾等。
以上所述,仅是本发明的较佳实施例而已,并非对本发明作任何形式上的限制,本领域技术人员利用上述揭示的技术内容做出些许简单修改、等同变化或修饰,均落在本发明的保护范围内。
Claims (4)
1.一种治疗神经衰弱、失眠的中药,其特征是由下列重量份的原料药组成:莲子心1.5~3重量份;香排草、香青兰3~9重量份;酸浆草、南蛇藤果、太白茶、太子参9~18重量份;舞草、粉条儿菜15~30重量份。
2.根据权利要求1所述的一种治疗神经衰弱、失眠的中药,其特征是由下列重量份的原料药组成:莲子心3重量份;香排草、香青兰9重量份;酸浆草、南蛇藤果、太白茶、太子参18重量份;舞草、粉条儿菜30重量份。
3.一种治疗神经衰弱、失眠的口服制剂,其特征是由权利要求1或2中任一项所述的中药组合物制成。
4.根据权利要求3所述的一种治疗神经衰弱、失眠的口服制剂,其特征是包括口服液、片剂、胶囊剂、丸剂,优选口服液和片剂。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2020104638958 | 2020-05-28 | ||
CN202010463895.8A CN111481633A (zh) | 2020-05-28 | 2020-05-28 | 一种治疗神经衰弱、失眠的中药组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113304227A true CN113304227A (zh) | 2021-08-27 |
Family
ID=71790860
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010463895.8A Pending CN111481633A (zh) | 2020-05-28 | 2020-05-28 | 一种治疗神经衰弱、失眠的中药组合物 |
CN202110568034.0A Pending CN113304227A (zh) | 2020-05-28 | 2021-05-25 | 一种治疗神经衰弱、失眠的中药组合物 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010463895.8A Pending CN111481633A (zh) | 2020-05-28 | 2020-05-28 | 一种治疗神经衰弱、失眠的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN111481633A (zh) |
-
2020
- 2020-05-28 CN CN202010463895.8A patent/CN111481633A/zh active Pending
-
2021
- 2021-05-25 CN CN202110568034.0A patent/CN113304227A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
CN111481633A (zh) | 2020-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102600417B (zh) | 一种治疗牛羊瘤胃鼓气的中药组合物 | |
CN110585413A (zh) | 治疗小儿感冒咳嗽、腹痛腹泻的中药贴敷膏及其制备方法 | |
CN107320555A (zh) | 一种具有抗疲劳作用的药物组合物及其制备方法和用途 | |
CN104083438A (zh) | 一种缓解高血压的苦瓜中药制剂及制备方法 | |
CN107875370A (zh) | 用于促进肠蠕动排气防止肠粘连的中药组合物及制备方法 | |
CN113181258A (zh) | 一种治疗月经不调、痛经、闭经的中药组合物 | |
CN106822660A (zh) | 一种治疗心脑血管疾病的中药制剂 | |
CN113304227A (zh) | 一种治疗神经衰弱、失眠的中药组合物 | |
CN102670948A (zh) | 一种冬果梨润肺平喘止咳露及其制备方法 | |
CN111617153A (zh) | 一种用于补虚劳、壮元阳的中药组合物及其制剂和应用 | |
CN104971286A (zh) | 一种治疗肩腰腿不适症的中药组合物 | |
CN107929644A (zh) | 一种治疗窦性心动过缓的中药组合物及其制备方法 | |
CN107854662A (zh) | 一种治疗肝硬化腹水的中药制剂及其制备方法 | |
CN108126161A (zh) | 一种治疗高血压的中草药及其制备方法和应用 | |
CN107080805A (zh) | 用于治疗冠心病的中药组合物及制备方法 | |
CN105596770A (zh) | 一种用于促进骨折愈合的外用药膏及制备方法 | |
CN105168945A (zh) | 一种用于促进骨折愈合的外用药膏及制备方法 | |
CN111714601A (zh) | 一种治疗真菌感染的中药组合物 | |
CN111729008A (zh) | 一种治疗贫血的中药组合物 | |
CN112426492A (zh) | 一种治疗止汗的中药组合物 | |
CN103356984B (zh) | 一种防治女性缺铁性贫血的中药组合物 | |
CN116672398A (zh) | 一种祛湿中药组合制剂及其制备方法 | |
CN114601900A (zh) | 一种幼儿增高健脾益智膏的配方及制备方法 | |
CN104027766A (zh) | 一种治疗尿毒症的中药组合物 | |
CN103479821B (zh) | 一种补肾益血的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20210827 |